Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis

European Journal of Neurology

Volumn 11, Issue 8, 2004, Pages 541-544

  Yilmaz, O ^a   Karaduman, A ^a   Topaloglu H ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Ambulation; Ankle contractures; Duchenne muscular dystrophy; Evolution; Outcome measures; Prednisolone; Scoliosis; Therapy

Indexed keywords

PREDNISOLONE; VITAMIN D;

ANKLE; ARTICLE; CHILD; CONTRACTURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DUCHENNE MUSCULAR DYSTROPHY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; MUSCLE STRENGTH; ONSET AGE; PRIORITY JOURNAL; SCOLIOSIS; STATISTICAL SIGNIFICANCE; VITAMIN INTAKE; WALKING;

ADOLESCENT; ANKLE; ANTI-INFLAMMATORY AGENTS; CALCIUM; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY, DUCHENNE; PREDNISOLONE; SCOLIOSIS; TIME FACTORS; TREATMENT OUTCOME; VITAMIN D; WALKING;

EID: 4043074853     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2004.00866.x     Document Type: Article

References (21)

1. Allsop K, Ziter FA (1981). Loss of strength and functional decline in Duchenne's dystrophy. Arch Neurol 38:406-411.
2. Angelini C, Bonifati DM (2000). New therapies in muscular dystrophies. Neurol Sci 21:919-924.
3. Beckman E, Henriksson KG (1995). Low-dose prednisolone treatment in Duchenne and Becker muscular dystrophy. Neuromuscular Disorders 5:233-241.
4. Biggar DW, Gingras M, Fehlings DL et al. (2001). Deflazacort treatment of Duchenne muscular dystrophy. The Journal of Pediatrics 138:45-50.
5. Blake DJ, Kröger S (2000). The neurobiology of Duchenne muscular dystrophy, learning lessons from muscle. TINS 23:92-99.
6. Bonifati M, Ruzza M, Bonometto P et al. (2000). A multicenter, double-blind, randomized tiral of deflazacort versus prednisone in Duchenne muscular dystrophy. Muscle and Nerve 23:1344-1347.
7. Daniels L, Worthingham C (1972). Muscle Testing. WB Saunders Company, Philadelphia, PA.
8. Drachman DM, Toyka KV, Myer E (1974). Prednisone in Duchenne muscular dystrophy. Lancet 14:1409-1412.
9. Dubowitz W (1994). The muscular dystrophies. In: Dubowitz W ed. Muscle Disorders In Childhood. WB Saunders Company, London, pp. 34-234.
10. Fenichel GM, Mendell JR, Moxley RT et al. (1991). A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy. Arch Neurol 48:575-579.
11. Fenichel GM, Griggs RC, Kissel J et al. (2001). A randomized efficiacy and safety trial of oxandrolone in the tratment of Duchenne dystrophy. Neurology 56:1075-1079.
12. King WM, Ruttencutter RE, Hoyle CJ et al. (2003). Orthopedic effects of steroid threatment in Duchenne dystrophy. Neurology 60(Suppl 1):A234.
13. Kissel JT, Burrow KR, Rammohan KW et al. (1991). Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. Neurology 41:667-672.
14. Matecki S, Topin N, Hayot M et al. (2001). A standardized method for evaluation of respiratory muscle endurance in patients with Duchenne muscular dystrophy. Neuromuscular Disorders 11:171-177.
15. Matsumura K, Campbell KP (1994). Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve 17:2-15.
16. Mesa LE, Dubrowsky AL, Corderi J et al. (1992). Steroids in Duchenne muscular dystrophy. Neuromuscular Disorders 1:261-266.
17. Sansome A, Royston P, Dubowitz W (1993). Steroids in Duchenne muscular dystrophy; pilot study of a new low-dosage schedule. Neuromuscular Disorders 3:567-569.
18. Tunca O, Kabakus N, Hergüner Ö et al. (2001). Alteranete day prednisolone therapy in Duchenne muscular dystrophy. Neuromuscular Disorders 11:630.
19. European Neuromuscular Centre (2000). 2nd Workshop on the Treatment of Muscular Dystrophy, 10-12 December 1999, Naarden, The Netherlands. Neuromuscular Disorders 10:313-320.
20. Zatz M, Pavanello RCM, Vainzof M et al. (1992). Steroids in Duchenne muscular dystrophy. Neuromuscular Disorders 2:59.
21. Zeman RJ, Peng H, Danon MJ et al. (2000). Clenbuterol reduces degeneration of exercised aged dystrophic (mdx) muscle. Muscle Nerve 23:521-528.